BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 21585431)

  • 1. Hepatoma-derived growth factor is a novel prognostic factor for cervical squamous cell carcinoma.
    Ye F; Cheng Q; Zhou C; Ma J; Chen H
    Histopathology; 2011 May; 58(6):982-4. PubMed ID: 21585431
    [No Abstract]   [Full Text] [Related]  

  • 2. Discrepancies in expression and prognostic value of tumor markers in adenocarcinoma and squamous cell carcinoma in cervical cancer.
    Lindström AK; Tot T; Stendahl U; Syrjänen S; Syrjänen K; Hellberg D
    Anticancer Res; 2009 Jul; 29(7):2577-8. PubMed ID: 19596931
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LRIG2 in contrast to LRIG1 predicts poor survival in early-stage squamous cell carcinoma of the uterine cervix.
    Hedman H; Lindström AK; Tot T; Stendahl U; Henriksson R; Hellberg D
    Acta Oncol; 2010 Aug; 49(6):812-5. PubMed ID: 20553099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatoma-derived growth factor as a prognostic marker in completely resected non-small-cell lung cancer.
    Iwasaki T; Nakagawa K; Nakamura H; Takada Y; Matsui K; Kawahara K
    Oncol Rep; 2005 Jun; 13(6):1075-80. PubMed ID: 15870924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of p16 INK4 expression in invasive squamous cell carcinoma of the uterine cervix is an adverse prognostic marker.
    Masoudi H; Van Niekerk DJ; Gilks CB; Cheang M; Bilek K; Fischer U; Ehlen T; Miller D; Horn LC
    Histopathology; 2006 Nov; 49(5):542-5. PubMed ID: 17064304
    [No Abstract]   [Full Text] [Related]  

  • 6. LA-1 oncogene. A possible new prognostic index for evaluating cervical squamous intraepithelial lesions.
    Sainz de la Cuesta R; Reed TP; Brothman JC; Dubin NH
    J Reprod Med; 1993 Mar; 38(3):173-8. PubMed ID: 8487232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Some kinetic characteristics of cervical cancer].
    Zharinov GM; Pozharisskiĭ KM; Vinokurov VL; Neklasova NIu; Mironovskaia NV; Kuznetsova ME; Tarkova AB
    Vopr Onkol; 2009; 55(2):196-200. PubMed ID: 19514375
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Markers of apoptosis in stage IB squamous cervical carcinoma.
    Van de Putte G; Holm R; Lie AK; Baekelandt M; Kristensen GB
    J Clin Pathol; 2005 Jun; 58(6):590-4. PubMed ID: 15917408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of c-KIT (CD117) occurs infrequently in squamous cell carcinoma of the uterine cervix.
    Han CP; Lin WL; Wang PH; Yang SF; Lewis JS; Chen CK; Ruan A; Kuo JF; Lee MY; Chiang H
    Histopathology; 2011 May; 58(6):988-90. PubMed ID: 21585433
    [No Abstract]   [Full Text] [Related]  

  • 10. [Tumor-associated trypsin inhibitor--an expanded tumor marker spectrum in cervix cancer?].
    Medl M; Ogris E; Fuchs G; Leodolter S
    Gynakol Rundsch; 1990; 30 Suppl 1():118-21. PubMed ID: 2079243
    [No Abstract]   [Full Text] [Related]  

  • 11. [Expression of ETV5 and MMP-7 in early stage cervical squamous cell carcinoma and its role in lymphatic metastasis].
    Wu SH; Zhang J; Li Y; Li JM
    Ai Zheng; 2006 Mar; 25(3):315-9. PubMed ID: 16536985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A case of hCG-producing cervical carcinoma of uterus].
    Ohara A; Yamada S; Suzuki N; Okagaki A; Shibamoto T; Nagano T; Nakai Y; Ban C; Tamura H; Suzuki A
    Nihon Sanka Fujinka Gakkai Zasshi; 1993 Nov; 45(11):1333-6. PubMed ID: 8258734
    [No Abstract]   [Full Text] [Related]  

  • 13. Prognostic impact of HIF-1alpha expression in patients with definitive radiotherapy for cervical cancer.
    Dellas K; Bache M; Pigorsch SU; Taubert H; Kappler M; Holzapfel D; Zorn E; Holzhausen HJ; Haensgen G
    Strahlenther Onkol; 2008 Mar; 184(3):169-74. PubMed ID: 18330514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of EphA2 and EphrinA-1 in squamous cell cervical carcinoma.
    Wu D; Suo Z; Kristensen GB; Li S; Troen G; Holm R; Nesland JM
    Gynecol Oncol; 2004 Aug; 94(2):312-9. PubMed ID: 15297167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Squamous cell carcinoma antigen].
    Nawata S; Sugino N; Kato H
    Nihon Rinsho; 2005 Aug; 63 Suppl 8():684-6. PubMed ID: 16149611
    [No Abstract]   [Full Text] [Related]  

  • 16. Usefulness of p16 for differentiating primary pulmonary squamous cell carcinoma from cervical squamous cell carcinoma metastatic to the lung.
    Wang CW; Wu TI; Yu CT; Wu YC; Teng YH; Chin SY; Lai CH; Chen TC
    Am J Clin Pathol; 2009 May; 131(5):715-22. PubMed ID: 19369633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Immunomorphological studies of the antigen associated with squamous cell cancer of the human cervix uteri].
    Ievleva ES; Marshutina NV; Ageenko AN; Khmel'nitskaia NG
    Biull Eksp Biol Med; 1992 Mar; 113(3):304-6. PubMed ID: 1421235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pitfalls in immunohistochemical validation of tumor marker expression--exemplified in invasive cancer of the uterine cervix.
    Hellberg D; Tot T; Stendahl U
    Gynecol Oncol; 2009 Jan; 112(1):235-40. PubMed ID: 18976801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of heat shock protein 27 in squamous cell carcinoma of the uterine cervix.
    El-Ghobashy AA; Herrington CS
    Hum Pathol; 2009 Nov; 40(11):1668-9; author reply 1669. PubMed ID: 19747712
    [No Abstract]   [Full Text] [Related]  

  • 20. Prognostic significance of Bax, Bcl-2, and p53 expressions in cervical squamous cell carcinoma treated by radiotherapy.
    Wootipoom V; Lekhyananda N; Phungrassami T; Boonyaphiphat P; Thongsuksai P
    Gynecol Oncol; 2004 Sep; 94(3):636-42. PubMed ID: 15350352
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.